Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid + cetylpyridinium chloride mouthwash versus chlorhexidine after crown lengthening surgery
IRCT20260206068771N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Feb 2026
- Modality
- Small Molecules, Conventional Liposomes → Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative oral hemorrhage and dental plaque comparing Tranexamic acid + cetylpyridinium chloride mouthwash with Chlorhexidine mouthwash (2 arms). Primary endpoints: Presence or absence of bleeding and O'Leary plaque index. Started Feb 2026; status: completed.
02
Drugs
tranexamic acidcetylpyridinium chloridechlorhexidine
03
Conditions
postoperative oral hemorrhagedental plaque
Beyond the preview
Go deeper on IRCT20260206068771N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260206068771N1.